In the US, Cowen & Co estimated vaping represents 24% of the REC market, and many expected vape pens would be the first REC 2.0 product to explode in popularity. After a summer of stock market losses, the industry was looking forward to new products to buck them up. For them, the U.S. vape crisis couldn’t have been more poorly timed.
- Industry people trust Health Canada’s strict regulations will protect the Canadian public, though La resse discovered that a Canadian company applied for a patent on vitamin E as a viscosity agent for cannabis vaping liquid—the same chemical connected with many or most U.S. vape illnesses.
Bloomberg, La Presse—In French
- A coalition of several medical groups called on Ottawa to subject vape products to the same strict limits on advertising and flavouring as tobacco.
- Rumours are circulating that Health Canada may delay legalizing vape devices until after October 17, but there’s little to suggest this is true. One insider suggested the real challenge for manufacturers will be due diligence that their hardware does not allow metal leeching. Twitter—Matthew Greenberg, Aaron W. Anderson
- The Canadian Centre for Substance Use and Addiction launched its searchable Canadian Cannabis Research Database, charting cannabis research under 40 topic headings.
- Aphria launched a program for parents to discuss cannabis use with their children. They partnered with Drug Free Kids Canada, an organization with which Health Canada severed ties in November after learning it was founded by a donation from opioid company Purdue Pharma.
Winsor Star, Hill Times